Glycerin_monoguaiacol_ether
Category
Glycerin_monoguaiacol_ether Brand names, Glycerin_monoguaiacol_ether Analogs
Glycerin_monoguaiacol_ether Brand Names Mixture
No information avaliable
Glycerin_monoguaiacol_ether Chemical_Formula
C10H14O4
Glycerin_monoguaiacol_ether RX_link
http://www.rxlist.com/cgi/generic2/guaifen.htm
Glycerin_monoguaiacol_ether fda sheet
Glycerin_monoguaiacol_ether msds (material safety sheet)
Glycerin_monoguaiacol_ether Synthesis Reference
No information avaliable
Glycerin_monoguaiacol_ether Molecular Weight
198.216 g/mol
Glycerin_monoguaiacol_ether Melting Point
78.5 oC
Glycerin_monoguaiacol_ether H2O Solubility
50 mg/mL
Glycerin_monoguaiacol_ether State
Solid
Glycerin_monoguaiacol_ether LogP
0.95
Glycerin_monoguaiacol_ether Dosage Forms
Liquid; Powder for solution; Syrup; Tablet
Glycerin_monoguaiacol_ether Indication
Used to assist the expectoration of phlegm from the airways in acute respiratory tract infections.
Glycerin_monoguaiacol_ether Pharmacology
Guaifenesin is an expectorant which increases the output of phlegm (sputum) and bronchial secretions by reducing adhesiveness and surface tension. The increased flow of less viscous secretions promotes ciliary action and changes a dry, unproductive cough to one that is more productive and less frequent. By reducing the viscosity and adhesiveness of secretions, guaifenesin increases the efficacy of the mucociliary mechanism in removing accumulated secretions from the upper and lower airway.
Glycerin_monoguaiacol_ether Absorption
Rapidly absorbed from the GI tract
Glycerin_monoguaiacol_ether Toxicity
LD50 1510 mg/kg (rat, oral)
Glycerin_monoguaiacol_ether Patient Information
No information avaliable
Glycerin_monoguaiacol_ether Organisms Affected
Humans and other mammals
